Prehospital thrombolysis with reteplase: The Nijmegen/Rotterdam studyLAMFERS, Evert J. P; SCHUT, Astrid; HOOGHOUDT, Ton E. H et al.The American heart journal. 2003, Vol 146, Num 3, pp 479-483, issn 0002-8703, 5 p.Article

Reteplase for clearance of occluded venous cathetersOWENS, Larry.American journal of health-system pharmacy. 2002, Vol 59, Num 17, pp 1638-1640, issn 1079-2082Article

A fresh look at the molecular pharmacology of plasminogen activators : From theory to test tube to clinical outcomesSMALLING, R. W.American journal of health-system pharmacy. 1997, Vol 54, Num 22, pp S17-S22, issn 1079-2082, SUP1Conference Paper

The concept of equivalence and its application to the assessment of thrombolytic effectsHAMPTON, J. R.European heart journal. 1997, Vol 18, Num DEC, pp F22-F27, issn 0195-668X, SUPFConference Paper

The platelet-related effects of tenecteplase versus alteplase versus reteplaseGURBEL, Paul A; HAYES, Kevin; BLIDEN, Kevin P et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 1, pp 1-7, issn 0957-5235, 7 p.Article

Combination pharmacotherapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa inhibitionBUSH, Howard S.The Journal of emergency medicine. 2003, Vol 25, Num 4, pp 421-426, issn 0736-4679, 6 p.Article

Benefical effects of reteplase in combination with abciximab: Platelet/leukocyte interactions and coagulation systemSZABO, S; WALTER, T; ETZEL, D et al.International journal of clinical pharmacology research. 2003, Vol 23, Num 2-3, pp 37-40, issn 0251-1649, 4 p.Article

Evaluation of the time saved by Prehospital initiation of reteplase for ST-elevation myocardial infarction: Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trialMORROW, David A; ANTMAN, Elliott M; MCCABE, Carolyn H et al.Journal of the American College of Cardiology. 2002, Vol 40, Num 1, pp 71-77, issn 0735-1097Article

Thrombolysis in pulmonary embolism : A debatable indicationGOLDHABER, Samuel Z.Thrombosis and haemostasis. 2001, Vol 86, Num 1, pp 444-451, issn 0340-6245Conference Paper

Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction : Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III TrialTOPOL, Eric J; OHMAN, E. Magnus; WHITE, Harvey D et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 15, pp 1761-1765, issn 0009-7322Article

Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine : Continuous platelet inhibition by the combination of abciximab and ticlopidinePETER, Karlheinz; KOHLER, Benedikt; STRAUB, Andreas et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 13, pp 1490-1496, issn 0009-7322Article

Current clinical use of reteplase for thrombolysis: A pharmacokinetic-pharmacodynamic perspectiveMARTIN, U; KAUFMANN, B; NEUGEBAUER, G et al.Clinical pharmacokinetics. 1999, Vol 36, Num 4, pp 265-276, issn 0312-5963Article

Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound : Comparison of nine plasminogen activators in vitroSAKHAROV, D. V; BARRETT-BERGSHOEFF, M; HEKKENBERG, R. T et al.Thrombosis and haemostasis. 1999, Vol 81, Num 4, pp 605-612, issn 0340-6245Article

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase: Results from GUSTO-IIIHASDAI, D; HOLMES, D. R; OHMAN, E. M et al.European heart journal. 1999, Vol 20, Num 2, pp 128-135, issn 0195-668XArticle

Reperfusion therapy for acute myocardial infarction : Which strategy for which patient?BOERSMA, E; STEYERBERG, E. W; VAN DER VLUGT, M. J et al.Drugs (Basel). 1998, Vol 56, Num 1, pp 31-48, issn 0012-6667Article

Results from late breaking clinical trials sessions at ACC '97Journal of the American College of Cardiology. 1997, Vol 30, Num 1, pp 1-7, issn 0735-1097Conference Proceedings

Thrombolytic therapy in acute myocardial infarctionHAMPTON, J. R.Cardiovascular drugs and therapy. 1997, Vol 11, pp 241-246, issn 0920-3206, SUP1Conference Paper

Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study) : results of a clinical pilot studyHELLEBREKERS, Bart W. J; TRIMBOS-KEMPER, Trudy C. M; BOESTEN, Lianne et al.Fertility and sterility. 2009, Vol 91, Num 4, pp 1204-1214, issn 0015-0282, 11 p.Article

Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab : results from the GUSTO-V trialNALLAMOTHU, Brahmajee K; BATES, Eric R; LINCOFF, A. Michael et al.European heart journal. 2005, Vol 26, Num 15, pp 1506-1512, issn 0195-668X, 7 p.Article

Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysisSZABO, S; ETZEL, D; EHLERS, R et al.Drugs under experimental and clinical research. 2004, Vol 30, Num 2, pp 47-54, issn 0378-6501, 8 p.Article

ST-segment resolution 60 minutes after combination treatment of Abciximab with Reteplase or Reteplase alone for Acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy)CURA, Fernando A; ROFFI, Marco; PASCA, Narcis et al.The American journal of cardiology. 2004, Vol 94, Num 7, pp 859-863, issn 0002-9149, 5 p.Article

Fibrinolysis for acute myocardial infarction: The future is here and nowARMSTRONG, Paul W; COLLEN, Désiré; ANTMAN, Elliott et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 20, pp 2533-2537, issn 0009-7322, 5 p.Article

Time to treatment and cost of thrombolysis : A multicenter comparison of tPA and rPASEYEDROUDBARI, A; KESSLER, E. R; MOOSS, A. N et al.Journal of thrombosis and thrombolysis. 2000, Vol 9, Num 3, pp 303-308, issn 0929-5305Article

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolismTEBBE, U; GRAF, A; KAMKE, W et al.The American heart journal. 1999, Vol 138, Num 1, pp 39-44, issn 0002-8703, 1Article

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinaseMOSER, M; NORDT, T; PETER, K et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 18, pp 1858-1864, issn 0009-7322Article